News for Healthier Living

Novel Antifungal Drug Shows Promise in Some Patients with Valley Fever

A subanalysis of a single-group, open-label, phase 2b study found that olorofim, a first-in-class orotomide antifungal agent that does not have U.S. FDA approval, showed efficacy in patients with disseminated coccidioidomycosis (DCM), a rare complication of Valley Fever where the fungus spreads from the lungs to other parts of the body.

July 20, 2026


July 21 2026

July 20 2026

July 17 2026

July 16 2026

July 15 2026

July 14 2026

July 13 2026

July 12 2026

July 10 2026

July 9 2026

July 8 2026

July 7 2026